Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0281 | ||||
| Gene Name | SLC32A1 | ||||
| Protein Name | Vesicular inhibitory amino acid transporter | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
| Synonyms | GABA and glycine transporter; SLC32A1; Solute carrier family 32 member 1; VGAT; VIAAT; Vesicular GABA transporter; hVIAAT | ||||
| DT Family | Amino Acid/Auxin Permease (AAAP) Family ; | ||||
| Tissue Specificity | Retina. Expressed throughout the horizontalcells or more specifically at the terminals. | ||||
| Function | This transporter is involved in the uptake of GABA and glycine into the synaptic vesicles. | ||||
| Endogenous Substrate(s) | Amino acids; H+ | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Gamma-aminobutyric acid
|
Phase 1/2 | Drug Info | Inflammatory bowel disease | DD7Z | [1] |
| References | |||||
| 1 | Wakefulness Is Governed by GABA and Histamine Cotransmission. Neuron. 2015 Jul 1;87(1):164-78. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.